表紙
市場調查報告書

病毒清除的全球市場

Viral Clearance

出版商 Global Industry Analysts, Inc. 商品編碼 893765
出版日期 內容資訊 英文 141 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
病毒清除的全球市場 Viral Clearance
出版日期: 2019年07月01日內容資訊: 英文 141 Pages
簡介

本報告提供全球病毒清除市場相關分析,整體市場規模的成果值、預測值,及主要推動及阻礙市場要素,各用途、各最終用途及各企業的市場佔有率趨勢 (過去9年、今後8年份),今後的市場成長的方向性,各地區、主要國家的市場詳細趨勢等調查,再加上主要企業簡介等資訊。

第1章 分析方法

第2章 摘要整理

  • 市場概要
    • 各企業的市場佔有率結構 (最新值、預測值)
  • 代表性企業分析
  • 市場趨勢與促進因素
  • 全球市場的未來展望
    • 市場規模、佔有率趨勢預測:各地區/各國
    • 基因改造蛋白質
      • 市場規模 (過去9年、今後8年份)
      • 市場佔有率:各企業 (總計17年份)
    • 血液/血液製劑
    • 疫苗
    • 其他的用途
    • 製藥企業/生物科技企業
    • CRO (醫藥品臨床研究委外機構)
    • 教育、研究機關
    • 其他最終用途

第3章 市場分析

  • 各地區的市場分析
    • 美國
      • 市場基本資料
      • 各企業市場佔有率
      • 病毒清除的市場規模 (成果值、預測值)
      • 各用途、各最終用途的市場規模 (成果值、預測值)
    • 加拿大
    • 日本
    • 中國
    • 歐洲
      • 法國
      • 德國
      • 義大利
      • 英國
      • 其他
    • 亞太地區
    • 其他國家 (RoW)

第4章 企業

  • AVANCE BIOSCIENCES INC.
  • BSL BIOSERVICE SCIENTIFIC LABORATORIES MUNICH GMBH
  • CHARLES RIVER LABORATORIES INTERNATIONAL
  • CLEAN CELLS INC.
  • LONZA GROUP AG
  • MERCK KGAA
  • SGS SA
  • SIGMA-ALDRICH CORPORATION
  • TEXCELL, INC.

第5章 相關分析

目錄
Product Code: MCP15504

Viral Clearance market worldwide is projected to grow by US$809.5 Million, guided by a compounded growth of 21.9%. Staying on top of trends is essential for decision makers to leverage this emerging opportunity. The report addresses this very need and provides the latest scoop on all major market segments. Recombinant Proteins, one of the segments analyzed and sized in this study, displays the potential to grow at over 22.1%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$209.7 Million by the year 2025, Recombinant Proteins will bring in healthy gains adding significant momentum to global growth.

While global megatrends sweeping through the market influence the primary direction of growth, regional markets are swayed by more granular locally unique business drivers. Representing the developed world, the United States will maintain a 26.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$64.4 Million to the region's size and clout in the next 5 to 6 years. Over US$48.4 Million worth of projected demand in the region will come from other emerging Eastern European markets. In Japan, Recombinant Proteins will reach a market size of US$13.3 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 20.2% over the next couple of years and add approximately US$127.8 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Avance Biosciences Inc. (USA); BSL BIOSERVICE Scientific Laboratories Munich GmbH (Germany); Charles River Laboratories International, Inc. (USA); Clean Cells Inc. (USA); Lonza Group AG (Switzerland); Merck KgaA (Germany); SGS SA (Switzerland); Sigma-Aldrich Corporation (USA); Texcell, Inc. (USA)

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
    • Viral Clearance Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Viral Clearance Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Viral Clearance Market Share Shift across Key Geographies Worldwide: 2019 VS 2025
  • TABLE 3: Recombinant Proteins (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025
  • TABLE 4: Recombinant Proteins (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2019 VS 2025
  • TABLE 5: Blood and Blood Products (Application) Worldwide Sales in US$ Million by Region/Country: 2018-2025
  • TABLE 6: Blood and Blood Products (Application) Market Share Shift across Key Geographies: 2019 VS 2025
  • TABLE 7: Vaccines (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 8: Vaccines (Application) Market Share Breakdown by Region/Country: 2019 VS 2025
  • TABLE 9: Other Applications (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025
  • TABLE 10: Other Applications (Application) Share Breakdown Review by Region/Country: 2019 VS 2025
  • TABLE 11: Pharmaceutical & Biotechnology (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 12: Pharmaceutical & Biotechnology (End-Use) Distribution of Global Sales by Region/Country: 2019 VS 2025
  • TABLE 13: CROs (End-Use) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2018 through 2025
  • TABLE 14: CROs (End-Use) Global Market Share Distribution by Region/Country for 2019 and 2025
  • TABLE 15: Academic Research Institutes (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025
  • TABLE 16: Academic Research Institutes (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2019 VS 2025
  • TABLE 17: Other End-Uses (End-Use) Worldwide Sales in US$ Million by Region/Country: 2018-2025
  • TABLE 18: Other End-Uses (End-Use) Market Share Shift across Key Geographies: 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

  • Market Facts & Figures
    • US Viral Clearance Market Share (in %) by Company: 2019 & 2025
  • TABLE 19: United States Viral Clearance Latent Demand Forecasts in US$ Million by Application: 2018 to 2025
  • TABLE 20: Viral Clearance Market Share Breakdown in the United States by Application: 2019 VS 2025
  • TABLE 21: United States Viral Clearance Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025
  • TABLE 22: Viral Clearance Market Share Breakdown in the United States by End-Use: 2019 VS 2025

CANADA

  • TABLE 23: Canadian Viral Clearance Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025
  • TABLE 24: Canadian Viral Clearance Market Share Analysis by Application: 2019 VS 2025
  • TABLE 25: Canadian Viral Clearance Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
  • TABLE 26: Canadian Viral Clearance Market Share Analysis by End-Use: 2019 VS 2025

JAPAN

  • TABLE 27: Japanese Demand Estimates and Forecasts for Viral Clearance in US$ Million by Application: 2018 to 2025
  • TABLE 28: Viral Clearance Market Share Shift in Japan by Application: 2019 VS 2025
  • TABLE 29: Japanese Demand Estimates and Forecasts for Viral Clearance in US$ Million by End-Use: 2018 to 2025
  • TABLE 30: Viral Clearance Market Share Shift in Japan by End-Use: 2019 VS 2025

CHINA

  • TABLE 31: Chinese Demand for Viral Clearance in US$ Million by Application: 2018 to 2025
  • TABLE 32: Chinese Viral Clearance Market Share Breakdown by Application: 2019 VS 2025
  • TABLE 33: Chinese Demand for Viral Clearance in US$ Million by End-Use: 2018 to 2025
  • TABLE 34: Chinese Viral Clearance Market Share Breakdown by End-Use: 2019 VS 2025

EUROPE

  • Market Facts & Figures
    • European Viral Clearance Market: Competitor Market Share Scenario (in %) for 2019 & 2025
  • TABLE 35: European Viral Clearance Market Demand Scenario in US$ Million by Region/Country: 2018-2025
  • TABLE 36: European Viral Clearance Market Share Shift by Region/Country: 2019 VS 2025
  • TABLE 37: European Viral Clearance Addressable Market Opportunity in US$ Million by Application: 2018-2025
  • TABLE 38: European Viral Clearance Market Share Analysis by Application: 2019 VS 2025
  • TABLE 39: European Viral Clearance Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
  • TABLE 40: European Viral Clearance Market Share Analysis by End-Use: 2019 VS 2025

FRANCE

  • TABLE 41: Viral Clearance Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025
  • TABLE 42: French Viral Clearance Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025
  • TABLE 43: Viral Clearance Quantitative Demand Analysis in France in US$ Million by End-Use: 2018-2025
  • TABLE 44: French Viral Clearance Market Share Analysis: A 7-Year Perspective by End-Use for 2019 and 2025

GERMANY

  • TABLE 45: Viral Clearance Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025
  • TABLE 46: Viral Clearance Market Share Distribution in Germany by Application: 2019 VS 2025
  • TABLE 47: Viral Clearance Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025
  • TABLE 48: Viral Clearance Market Share Distribution in Germany by End-Use: 2019 VS 2025

ITALY

  • TABLE 49: Italian Demand for Viral Clearance in US$ Million by Application: 2018 to 2025
  • TABLE 50: Italian Viral Clearance Market Share Breakdown by Application: 2019 VS 2025
  • TABLE 51: Italian Demand for Viral Clearance in US$ Million by End-Use: 2018 to 2025
  • TABLE 52: Italian Viral Clearance Market Share Breakdown by End-Use: 2019 VS 2025

UNITED KINGDOM

  • TABLE 53: United Kingdom Demand Estimates and Forecasts for Viral Clearance in US$ Million by Application: 2018 to 2025
  • TABLE 54: Viral Clearance Market Share Shift in the United Kingdom by Application: 2019 VS 2025
  • TABLE 55: United Kingdom Demand Estimates and Forecasts for Viral Clearance in US$ Million by End-Use: 2018 to 2025
  • TABLE 56: Viral Clearance Market Share Shift in the United Kingdom by End-Use: 2019 VS 2025

REST OF EUROPE

  • TABLE 57: Rest of Europe Viral Clearance Addressable Market Opportunity in US$ Million by Application: 2018-2025
  • TABLE 58: Rest of Europe Viral Clearance Market Share Analysis by Application: 2019 VS 2025
  • TABLE 59: Rest of Europe Viral Clearance Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
  • TABLE 60: Rest of Europe Viral Clearance Market Share Analysis by End-Use: 2019 VS 2025

ASIA-PACIFIC

  • TABLE 61: Viral Clearance Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025
  • TABLE 62: Asia-Pacific Viral Clearance Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025
  • TABLE 63: Viral Clearance Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2018-2025
  • TABLE 64: Asia-Pacific Viral Clearance Market Share Analysis: A 7-Year Perspective by End-Use for 2019 and 2025

REST OF WORLD

  • TABLE 65: Rest of World Viral Clearance Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025
  • TABLE 66: Rest of World Viral Clearance Market Share Analysis by Application: 2019 VS 2025
  • TABLE 67: Rest of World Viral Clearance Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
  • TABLE 68: Rest of World Viral Clearance Market Share Analysis by End-Use: 2019 VS 2025

IV. COMPETITION

  • AVANCE BIOSCIENCES INC.
  • BSL BIOSERVICE SCIENTIFIC LABORATORIES MUNICH GMBH
  • CHARLES RIVER LABORATORIES INTERNATIONAL
  • CLEAN CELLS INC.
  • LONZA GROUP AG
  • MERCK KGAA
  • SGS SA
  • SIGMA-ALDRICH CORPORATION
  • TEXCELL, INC.

V. CURATED RESEARCH

Back to Top